Clinical Trials Logo

Lung Neoplasms clinical trials

View clinical trials related to Lung Neoplasms.

Filter by:

NCT ID: NCT02914990 Completed - Clinical trials for Non-Small Cell Lung Cancer

Safety, Tolerability and Pharmacokinetic Profile of BPI-15086 in EGFR T790M Mutation-positive NSCLC Patients

Start date: December 29, 2016
Phase: Phase 1
Study type: Interventional

The main objective of this study is to evaluate the safety and tolerability of BPI-15086.

NCT ID: NCT02914899 Active, not recruiting - Clinical trials for Lung Cancer Screening

Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community

Start date: August 2016
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to test if our Community Health Worker program can help at-risk NYC Chinese community members participate in shared decision making and lung cancer screening (if appropriate) and compare it to the help provided by written materials.

NCT ID: NCT02913443 Completed - Clinical trials for Small Cell Lung Cancer

A Dose Finding and Expansion Study of RO7051790 Administered Orally in Participants With Relapsed, Extensive-Stage Disease Small Cell Lung Cancer (ED SCLC)

Start date: December 20, 2016
Phase: Phase 1
Study type: Interventional

This is a Phase I, open-label, multicenter study designed to assess the safety and tolerability of RO7051790 in participants with relapsed ED SCLC. This dose escalation and expansion study plans to determine the maximum tolerated dose and/or optimal biological dose as a recommended Phase 2 dose for RO7051790, based on the safety, tolerability, pharmacokinetic and pharmacodynamic profiles observed after oral administration of RO7051790.

NCT ID: NCT02911259 Completed - Clinical trials for Non-small Cell Lung Cancer

Suction on Post-Operative Chest Tubes

SPOCT
Start date: February 2016
Phase: N/A
Study type: Interventional

The level of suction on post-operative chest tubes after video-assisted thoracoscopic surgery (VATS) lobectomy for lung cancer has previously shown to affect duration of drainage. These results, however, are based on traditional drainage systems with water seal and need to be confirmed using digital drainage systems. Hypothesis: Suction of -2 cmH2O is equal to or superior compared with standard suction of -10 cmH2O when looking at chest tube duration and complications.

NCT ID: NCT02910999 Completed - Clinical trials for Non-Small Cell Lung Cancer

Real-Life Study With Nivolumab (BMS-936558) in Advanced NSCLC Patients After Prior Chemotherapy

ENLARGE-Lung
Start date: August 9, 2016
Phase:
Study type: Observational

This study intends to describe the real-life effectiveness and safety of nivolumab in advanced NSCLC patients in Germany, as well as the patient profile, pattern of use and the quality of life.

NCT ID: NCT02910453 Completed - Lung Cancer Clinical Trials

VATS Versus Open Pulmonary Lobectomy in the Limelight of OEP

VOLO
Start date: January 2015
Phase:
Study type: Observational

The standard operative approach to pulmonary lesions has been via postero-lateral thoracotomy and direct vision. This technique has some advantages but its morbidity is significant. Some surgeons advocate a resection by video-assisted thoracic surgery (VATS) to reduce the impact on chest wall and the impairment on respiratory mechanic. However, an evidence for superiority of the approach minimally invasive is lacking, particularly for the difficult assessment of the change in pulmonary function. The aim of this study is to compare VATS- over open lobectomy regarding the differences of chest wall kinematic, analyzed by optoelectronic plethysmography (OEP).

NCT ID: NCT02909452 Completed - Neoplasms Clinical Trials

Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors

Start date: September 20, 2016
Phase: Phase 1
Study type: Interventional

The objectives of this study are to explore different dosing levels and schedules of entinostat in combination with pembrolizumab in patients with advanced solid tumors, in terms of safety, tolerability, pharmacokinetics (PK), impact on immune correlatives, and efficacy

NCT ID: NCT02907606 Not yet recruiting - Lung Neoplasms Clinical Trials

Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective Study

Start date: September 2016
Phase: N/A
Study type: Observational [Patient Registry]

This study will evaluate the feasibility and effectiveness of urinary ctDNA detection and dynamic monitoring during treatment of NSCLC patients prospectively,by collecting and detecting tumor tissues, peripheral blood samples and urine samples of NSCLC patients.

NCT ID: NCT02906852 Completed - Clinical trials for Non-Small Cell Lung Cancer

Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing

Start date: August 1, 2016
Phase:
Study type: Observational

The aim of this study is to evaluate the performance of Inivata liquid biopsy analysis compared with standard tissue biopsy analysis for detection of genomic alterations in patients with advanced lung cancer.

NCT ID: NCT02906384 Recruiting - Clinical trials for Small Cell Lung Cancer

Memory and MRI Changes With Hippocampus Avoidance Prophylactic Cranial Irradiation(HA-PCI) for Small Cell Lung Cancer(SCLC)

Start date: October 2016
Phase: Phase 2
Study type: Interventional

This is a prospective, randomized phase-II study observing the memory preservation and functional brain MRI changes with conformal avoidance of the hippocampal neural stem-cell compartment during prophylactic cranial irradiation for small cell lung cancer patients.